These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 33969823)

  • 1. Iron Toxicity and Chelation Therapy in Hematopoietic Stem Cell Transplant.
    Isidori A; Loscocco F; Visani G; Chiarucci M; Musto P; Kubasch AS; Platzbecker U; Vinchi F
    Transplant Cell Ther; 2021 May; 27(5):371-379. PubMed ID: 33969823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impact of iron overload in hematopoietic stem cell transplantation.
    Wang C; Zhao M; Liu Q; Yang Y; Li Y; Nie Y; Gao S; Li W
    Transpl Immunol; 2023 Jun; 78():101820. PubMed ID: 36921731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Iron toxicity - Its effect on the bone marrow.
    Isidori A; Borin L; Elli E; Latagliata R; Martino B; Palumbo G; Pilo F; Loscocco F; Visani G; Cianciulli P
    Blood Rev; 2018 Nov; 32(6):473-479. PubMed ID: 29699840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of Iron Overload and Iron Chelation with Deferasirox on Outcomes of Patients with Severe Aplastic Anemia after Allogeneic Hematopoietic Stem Cell Transplantation.
    Pan T; Ji Y; Liu H; Tang B; Song K; Wan X; Yao W; Sun G; Wang J; Sun Z
    Transplant Cell Ther; 2023 Aug; 29(8):507.e1-507.e8. PubMed ID: 37116582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Management of iron overload before, during, and after hematopoietic stem cell transplantation for thalassemia major.
    Angelucci E; Pilo F
    Ann N Y Acad Sci; 2016 Mar; 1368(1):115-21. PubMed ID: 26999450
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of iron in patients after bone marrow transplantation.
    de Witte T
    Blood Rev; 2008 Dec; 22 Suppl 2():S22-8. PubMed ID: 19059053
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Free iron catalyzes oxidative damage to hematopoietic cells/mesenchymal stem cells in vitro and suppresses hematopoiesis in iron overload patients.
    Lu W; Zhao M; Rajbhandary S; Xie F; Chai X; Mu J; Meng J; Liu Y; Jiang Y; Xu X; Meng A
    Eur J Haematol; 2013 Sep; 91(3):249-261. PubMed ID: 23772810
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The bone marrow hematopoietic microenvironment is impaired in iron-overloaded mice.
    Okabe H; Suzuki T; Uehara E; Ueda M; Nagai T; Ozawa K
    Eur J Haematol; 2014 Aug; 93(2):118-28. PubMed ID: 24628561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A prospective non-interventional study on the impact of transfusion burden and related iron toxicity on outcome in myelodysplastic syndromes undergoing allogeneic hematopoietic cell transplantation
    Cremers EMP; de Witte T; de Wreede L; Eikema DJ; Koster L; van Biezen A; Finke J; Socié G; Beelen D; Maertens J; Nagler A; Kobbe G; Ziagkos D; Itälä-Remes M; Gedde-Dahl T; Sierra J; Niederwieser D; Ljungman P; Beguin Y; Ozkurt ZN; Anagnostopoulos A; Jindra P; Robin M; Kröger N
    Leuk Lymphoma; 2019 Oct; 60(10):2404-2414. PubMed ID: 30997844
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Effects of iron chelation therapy on allogeneic hematopoietic stem cell transplantation in myelodysplastic syndrome patients with iron overload].
    Gu CH; Li CX; Ye L; Liu H; Ma JF; Wang T; Zou Q; Chen J; Chen XC; Wu DP
    Zhonghua Xue Ye Xue Za Zhi; 2016 Mar; 37(3):189-93. PubMed ID: 27033754
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Toxicity of iron overload and iron overload reduction in the setting of hematopoietic stem cell transplantation for hematologic malignancies.
    Leitch HA; Fibach E; Rachmilewitz E
    Crit Rev Oncol Hematol; 2017 May; 113():156-170. PubMed ID: 28427505
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New insights into transfusion-related iron toxicity: Implications for the oncologist.
    Porter JB; de Witte T; Cappellini MD; Gattermann N
    Crit Rev Oncol Hematol; 2016 Mar; 99():261-71. PubMed ID: 26806144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The management of iron overload in allogeneic hematopoietic stem cell transplant (alloHSCT) recipients: where do we stand?
    Sivgin S; Eser B
    Ann Hematol; 2013 May; 92(5):577-86. PubMed ID: 23430087
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Iron Chelation with Deferasirox Suppresses the Appearance of Labile Plasma Iron During Conditioning Chemotherapy Prior to Allogeneic Stem Cell Transplantation.
    Essmann S; Heestermans M; Dadkhah A; Janson D; Wolschke C; Ayuk F; Kröger NM; Langebrake C
    Transplant Cell Ther; 2023 Jan; 29(1):42.e1-42.e6. PubMed ID: 36241148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bone marrow versus peripheral blood allogeneic haematopoietic stem cell transplantation for haematological malignancies in adults.
    Holtick U; Albrecht M; Chemnitz JM; Theurich S; Skoetz N; Scheid C; von Bergwelt-Baildon M
    Cochrane Database Syst Rev; 2014 Apr; 2014(4):CD010189. PubMed ID: 24748537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Iron overload in hematopoietic cell transplantation.
    Majhail NS; Lazarus HM; Burns LJ
    Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Assessment and management of post-transplant iron overload: Guidelines of the Francophone Society of Marrow Transplantation and Cellular Therapy (SFGM-TC)].
    Jaspers A; Bouhya S; Belaiche S; Chevallier P; Hermet E; Hospital-Gustems C; Michallet M; Rialland F; Samsonova O; Sirvent A; Yakoub-Agha I; Rohrlich PS; Beguin Y
    Bull Cancer; 2016 Nov; 103(11S):S255-S266. PubMed ID: 27842863
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-year results from a prospective randomized trial comparing phlebotomy with deferasirox for the treatment of iron overload in pediatric patients with thalassemia major following curative stem cell transplantation.
    Inati A; Kahale M; Sbeiti N; Cappellini MD; Taher AT; Koussa S; Nasr TA; Musallam KM; Abbas HA; Porter JB
    Pediatr Blood Cancer; 2017 Jan; 64(1):188-196. PubMed ID: 27576370
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rust and corrosion in hematopoietic stem cell transplantation: the problem of iron and oxidative stress.
    Evens AM; Mehta J; Gordon LI
    Bone Marrow Transplant; 2004 Oct; 34(7):561-71. PubMed ID: 15286699
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase IV open-label study of the efficacy and safety of deferasirox after allogeneic stem cell transplantation.
    Vallejo C; Batlle M; Vázquez L; Solano C; Sampol A; Duarte R; Hernández D; López J; Rovira M; Jiménez S; Valcárcel D; Belloch V; Jiménez M; Jarque I;
    Haematologica; 2014 Oct; 99(10):1632-7. PubMed ID: 24997153
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.